1. Lopez-Santillan, Maria, Iparraguirre, Leire, Martin-Guerrero, Idoia, Gutierrez-Camino, Angela, Garcia-Orad, Africa. . Review of pharmacogenetics studies of L-asparaginase hypersensitivity in acute lymphoblastic leukemia points to variants in the GRIA1 gene. In Drug metabolism and personalized therapy, 32, 1-9. doi:10.1515/dmpt-2016-0033. https://pubmed.ncbi.nlm.nih.gov/28259867/
2. Fang, Jie, An, Xingkai, Chen, Shuai, Ma, Qilin, Qu, Hongli. 2016. Case-control study of GRIA1 and GRIA3 gene variants in migraine. In The journal of headache and pain, 17, 2. doi:10.1186/s10194-016-0592-2. https://pubmed.ncbi.nlm.nih.gov/26800698/
3. Rajić, Vladan, Debeljak, Maruša, Goričar, Katja, Jazbec, Janez. 2015. Polymorphisms in GRIA1 gene are a risk factor for asparaginase hypersensitivity during the treatment of childhood acute lymphoblastic leukemia. In Leukemia & lymphoma, 56, 3103-8. doi:10.3109/10428194.2015.1020802. https://pubmed.ncbi.nlm.nih.gov/25697915/
4. Zhao, Meng, Dong, Junli, Liao, Yuanmei, Zuo, Xiaohua, Shan, Ben. . MicroRNA miR-18a-3p promotes osteoporosis and possibly contributes to spinal fracture by inhibiting the glutamate AMPA receptor subunit 1 gene (GRIA1). In Bioengineered, 13, 370-382. doi:10.1080/21655979.2021.2005743. https://pubmed.ncbi.nlm.nih.gov/34937502/
5. Ang, Gauri, Brown, Laurence A, Tam, Shu K E, Bannerman, David M, Peirson, Stuart N. 2021. Deletion of AMPA receptor GluA1 subunit gene (Gria1) causes circadian rhythm disruption and aberrant responses to environmental cues. In Translational psychiatry, 11, 588. doi:10.1038/s41398-021-01690-3. https://pubmed.ncbi.nlm.nih.gov/34782594/